These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2808215)

  • 1. The pharmacokinetics of meropenem in volunteers.
    Bax RP; Bastain W; Featherstone A; Wilkinson DM; Hutchison M; Haworth SJ
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():311-20. PubMed ID: 2808215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the pharmacokinetics of meropenem after administration by intravenous injection over 5 min and intravenous infusion over 30 min.
    Kelly HC; Hutchison M; Haworth SJ
    J Antimicrob Chemother; 1995 Jul; 36 Suppl A():35-41. PubMed ID: 8543497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The disposition and metabolism of meropenem in laboratory animals and man.
    Harrison MP; Moss SR; Featherstone A; Fowkes AG; Sanders AM; Case DE
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():265-77. PubMed ID: 2808212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of meropenem and its metabolite ICI 213,689 in healthy subjects with known renal metabolism of imipenem.
    Burman LA; Nilsson-Ehle I; Hutchison M; Haworth SJ; Norrby SR
    J Antimicrob Chemother; 1991 Feb; 27(2):219-24. PubMed ID: 2055812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-performance liquid chromatographic assay for meropenem in serum.
    Elkhaïli H; Niedergang S; Pompei D; Linger L; Leveque D; Jehl F
    J Chromatogr B Biomed Appl; 1996 Nov; 686(1):19-26. PubMed ID: 8953188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rapid, sensitive high performance liquid chromatographic method for the determination of meropenem in pharmaceutical dosage form, human serum and urine.
    Ozkan Y; Küçükgüzel I; Ozkan SA; Aboul-Enein HY
    Biomed Chromatogr; 2001 Jun; 15(4):263-6. PubMed ID: 11438968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meropenem pharmacokinetics in a patient with multiorgan failure from Meningococcemia undergoing continuous venovenous hemodiafiltration.
    Meyer MM; Munar MY; Kohlhepp SJ; Bryant RE
    Am J Kidney Dis; 1999 Apr; 33(4):790-5. PubMed ID: 10196026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma pharmacokinetics and urine concentrations of meropenem in ewes.
    Abo El Sooud K
    J Vet Pharmacol Ther; 2004 Feb; 27(1):27-30. PubMed ID: 14995963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrapulmonary pharmacokinetics and pharmacodynamics of meropenem.
    Conte JE; Golden JA; Kelley MG; Zurlinden E
    Int J Antimicrob Agents; 2005 Dec; 26(6):449-56. PubMed ID: 16280244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal handling of CS-023 (RO4908463), a novel parenteral carbapenem antibiotic, in rabbits in comparison with meropenem.
    Shibayama T; Yamamura N; Matsushita Y; Tokui T; Hirota T; Ikeda T
    Xenobiotica; 2006 Dec; 36(12):1273-87. PubMed ID: 17162472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma pharmacokinetics and tissue fluid concentrations of meropenem after intravenous and subcutaneous administration in dogs.
    Bidgood T; Papich MG
    Am J Vet Res; 2002 Dec; 63(12):1622-8. PubMed ID: 12492274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meropenem pharmacokinetics and penetration into an inflammatory exudate.
    Wise R; Logan M; Cooper M; Ashby JP; Andrews JM
    Antimicrob Agents Chemother; 1990 Aug; 34(8):1515-7. PubMed ID: 2221860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of meropenem in subjects with various degrees of renal impairment.
    Christensson BA; Nilsson-Ehle I; Hutchison M; Haworth SJ; Oqvist B; Norrby SR
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1532-7. PubMed ID: 1510451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penetration of meropenem into heart valve tissue.
    Newsom SW; Palsingh J; Wells FC; Kelly HC
    J Antimicrob Chemother; 1995 Jul; 36 Suppl A():57-62. PubMed ID: 8543499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The disposition and metabolic fate of 14C-meropenem in man.
    Harrison MP; Haworth SJ; Moss SR; Wilkinson DM; Featherstone A
    Xenobiotica; 1993 Nov; 23(11):1311-23. PubMed ID: 8310714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics of meropenem after the first and tenth intramuscular administration.
    Novelli A; Mazzei T; Meli E; Conti S; Fallani S; Periti P
    J Antimicrob Chemother; 1996 Apr; 37(4):775-81. PubMed ID: 8722543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of meropenem in subjects with renal insufficiency.
    Leroy A; Fillastre JP; Etienne I; Borsa-Lebás F; Humbert G
    Eur J Clin Pharmacol; 1992; 42(5):535-8. PubMed ID: 1607000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of meropenem in patients with various degrees of renal function, including patients with end-stage renal disease.
    Chimata M; Nagase M; Suzuki Y; Shimomura M; Kakuta S
    Antimicrob Agents Chemother; 1993 Feb; 37(2):229-33. PubMed ID: 8452352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the pharmacodynamics of meropenem in healthy volunteers following administration by intermittent infusion or bolus injection.
    Jaruratanasirikul S; Sriwiriyajan S
    J Antimicrob Chemother; 2003 Sep; 52(3):518-21. PubMed ID: 12917242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of meropenem in febrile neutropenic patients. Swedish study group.
    Nyhlén A; Ljungberg B; Nilsson-Ehle I
    Eur J Clin Microbiol Infect Dis; 1997 Nov; 16(11):797-802. PubMed ID: 9447900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.